Clinical significance of tumor markers in patients with type 2 diabetes: a retrospective observational study | SpringerLink
HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study | SpringerLink
High prevalence of abnormal CEA in diabetic inpatients | DMSO
The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels
shows that HbA1C had the strongest influence on CEA levels when age,... | Download Table
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
High prevalence of short-term elevation of tumor markers | DMSO
High prevalence of short-term elevation of tumor markers | DMSO
shows that HbA1C had the strongest influence on CEA levels when age,... | Download Table
PDF) Effect of glycemic status on serum CEA and CA 19-9 levels in patients of Diabetes Mellitus in Northern India
Positive rates of 4 tumor markers with single and combined detection in... | Download Table
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
High prevalence of short-term elevation of tumor markers | DMSO
Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung - Journal of Thoracic Oncology
Prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer
Diagnostic value of a panel of tumor markers as a part of a diagnostic work-up for ascites of unknown etiology
High prevalence of abnormal CEA in diabetic inpatients | DMSO
Graph of tumor marker carcinoembryonic antigen (CEA) vs. time, the... | Download Scientific Diagram
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
High prevalence of abnormal CEA in diabetic inpatients | DMSO
The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
Distribution of tumor marker levels in various patient groups. Box... | Download Scientific Diagram
